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Ancient schwannoma is rare in the adrenal gland and so is myelolipoma. These two uncommon tumors
existing together in one adrenal incidentaloma is extremely rare, and have gone unreported in the
literature to date. We describe a 47-year-old female case of ancient schwannoma and myelolipoma in a
left adrenal incidentaloma. The patient was obese with diabetes mellitus. Chronic epigastralgia and acute
hepatitis related to cholelithiasis was present. Abdominal computed tomography depicted a 7-cm left
adrenal incidentaloma. Fine-needle biopsy for diagnosis is challenging on retrospective reviews. Due to
the malignant potency of the tumor and symptomatic cholelithiasis, laparoscopic left adrenalectomy and
cholecystectomy were performed simultaneously. The only way to deﬁnitely diagnose adrenal
schwannoma is by immunohistochemical examination which exhibits positive for S-100 protein, but
negative for CD34, desmin, smooth muscle actin, and synaptophysin as in our case. We also discuss
clinical, pathological, and image characteristics of adrenal schwannoma and myelolipoma in the
literature.
Copyright © 2015, Taiwan Urological Association. Published by Elsevier Taiwan LLC.
Open access under CC BY-NC-ND license.1. Introduction
Schwannomas (neurilemomas), a kind of nerve sheath tumor,
presenting as an adrenal incidentaloma, is exceedingly rare.1 They
are benign lesions with a slow growth pattern and manifest mostly
in the head, neck, and extremities. Ancient schwannomas, also
described as degenerative neurilemomas, are a rare variant ﬁrst
described by Ackerman and Taylor in 1951. Ancient schwannomas
display distinctive features of degeneration including cystic for-
mation, calciﬁcation, stromal edema, hemorrhage, hyalinization,
fatty degeneration, nuclear pleomorphism, and hyperchromasia.
Degeneration is attributed to tumor growth over time leading to
vascular insufﬁciency. Nuclear atypia and hyperchromasia in pa-
thology cause confusion with malignancy; nevertheless, malignant
change of schwannoma is extremely infrequent and recurrence is
very rare even in incomplete resections.2Kaohsiung Municipal Hsiao-
ohsiung City 807, Taiwan.
).
ciation. Published by Elsevier TaiwMyelolipomas, also relatively uncommon in adrenal glands,
consist of variable proportions of mature adipose and hematopoi-
etic tissue. Both sexes are affected almost equally with peak prev-
alence between 40 years and 69 years of age. The majority of cases
are asymptomatic, nonfunctioning, small, and unilateral. Their
incidence has increased in recent periods because of increased use
of imaging examinations for unrelated symptoms. Despite their
benign nature, tumors >7 cm or symptomatic myelolipomas should
be removed surgically. Recurrence is seldom noted.1,3
We describe a rare case of an adrenal incidentaloma composed
of ancient schwannoma and myelolipoma. This is the ﬁrst report
concerning these two uncommon tumors in one visceral location.
We also review the literature on their etiology, clinicopathology,
and radiological features.2. Case report
A 47-year-old female had a medical history of diabetes mellitus
and obesity. She suffered from intermittent epigastralgia radiation
to the back, vomiting, general malaise, and becoming easily
fatigued for 3 months. She visited our gastroenterologicalan LLC. Open access under CC BY-NC-ND license.
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(GOT)/glutamic pyruvic transaminase (GPT) levels, and total bili-
rubin levels were noted which were 148/47 IU/L and 1.19 mg/dL
respectively. After follow-up (of blood analysis ), GOT/GPT
increased to 430/329 IU/L so she was admitted for acute hepatitis
survey. Series investigations including abdominal computed to-
mography (CT) were carried out. Cholelithiasis with cholecystitis
was noted, therefore, cholestatic type hepatitis was impressed.
Furthermore, a 7-cm soft tissue lesion in the left adrenal gland with
calciﬁcation and some fat component was found incidentally
(Fig. 1). Left adrenal teratoma or myelolipoma with superimposed
primary or secondary malignancy was suspected. The patient was
then referred to the hepatobiliary surgeon and urologist for further
management. Endocrine studies with vanillylmandelic acid (VMA)
of urine was 4.91 mg/day, aldosterone was 4.16 ng/dL, and cortisol
in the morning (9 AM) and afternoon (2 PM) were 17.3mg/dL and
15.3mg/dL, respectively. Due to symptomatic cholelithiasis and po-
tency of malignant adrenal tumor, simultaneous laparoscopic
cholecystectomy and left adrenalectomy were performed.
The specimen of adrenal tumor was 7 cm  3.8 cm  3.5 cm in
size. On section, it showed two yellow tumors measuring
3.5 cm  3.2 cm  3 cm and 2 cm  1.5 cm  1.5 cm. Moreover, a
brownish-tan tumor measuring 3 cm  2.5 cm  1 cm was also
seen. Microscopically, it showed encapsulated tumors composed of
ovoid or spindle cells in interlacing fascicles or palisading pattern
admixed with hypocellular myxoid areas. There were scattered
giant cells with degenerated atypia. Focal inﬂammation, ﬁbrosis,
sclerotic change, and calciﬁcation were also noted (Fig. 2). The
immunohistochemical stains revealed positive reaction with S-100Fig. 1. (A, B) Transverse views of enhanced abdominal CT show left adrenal tumor with calprotein, but negative with CD34, desmin, smooth muscle actin, and
synaptophysin. These features suggested an ancient schwannoma
(degenerative neurilemoma). There was a small regional lymph
node. Moreover, a myelolipoma composed of hematopoietic ele-
ments and mature adipose cells was also seen (Fig. 3). Pathology of
the gallbladder was cholelithiasis with acute exacerbation of
chronic cholecystitis. The patient's postoperative course was un-
eventful and shewaswell without evidence of recurrence at 2 years
follow up.
3. Discussion
Schwannomas (neurilemomas) are rare tumors with a benign,
slow-growing nature. Grossly, they are solitary, well-circumscribed,
and encapsulated subcutaneous tumors. Malignant potency is < 1%.
They could be multiple and originate from the nerve sheath of the
peripheral/cranial nerves, spinal plexus, or roots within the head,
neck, stomach, or extremities, and even in the retroperitoneal
cavity, liver, pancreas, kidneys, and heart.4 Visceral involvement,
especially the adrenal gland, is extremely rare and usually discov-
ered incidentally. Adrenal schwannomas affect both sexes equally
within a wide age range, without racial predilection. Although they
might be asymptomatic, the patient can present vague abdominal
pain, ﬂank pain, lower back pain, or hematuria. No biochemical or
clinical hormone activity was learned. In 1908, Verocay ﬁrst illus-
trated schwannoma which were then subclassiﬁed into two
distinct histological patterns by Antoni in 1920. The morphologic
characters of adrenal schwannomas may be conventional or with
cellular variants. Antoni illustrated two distinct architectures ofciﬁcation and some fat component; (C, D) coronal views. CT ¼ computed tomography.
Fig. 2. (A) The cut surface of the tumor shows encapsulated, yellowish-tan, lobulated schwannoma (right ﬁeld), brownish-tan myelolipoma (left ﬁeld), and thinned adrenal pa-
renchyma (arrows); (B) a low power view demonstrates neurilemoma (upper and left ﬁelds) and myelolipoma (central ﬁeld) in the multinodular tumor with thinned adrenal
parenchyma (arrows). (Hematoxylin and eosin stain; original magniﬁcation, 2.) (C) The degenerative neurilemoma is composed of spindle cells in interlacing fascicles with ﬁbrosis
and lymphoid aggregation (arrowheads) and rimmed by adrenal parenchyma (arrows). (Hematoxylin and eosin stain; original magniﬁcation, 4.) (D) Antoni A pattern is char-
acterized by spindle cells with nuclear palisading (arrows) in the neurilemoma. (Hematoxylin and eosin stain; original magniﬁcation, 20.)
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cellular areas with alternating compact spindle cells and nuclear
palisades. Antoni B displays loosely textured, paucicellular areas.2,4
Immunohistological staining is essential to conﬁrm diagnosis of
schwannomawith diffuse reactivity for S-100 protein, laminin, and
vimentin. They also usually show pericellular positivity for collagen
IV and <1% immunoreactivity for Ki-67. Using immunohisto-
chemistry, further differential diagnosis can be performed easily.
Positive calretinin, a calcium-binding protein belonging to the same
protein family as S-100, will exclude neuroﬁbromas, which are
similar to schwannomas due to positive staining for S-100 protein
in some rare cases. Desmin and smooth muscle actin are positive
for leiomyomas. Chromogranin and synaptophysin are regularly
positive for pheochromocytomas, which lack S-100 protein. C-kit
has a 95% positive rate for gastrointestinal stromal tumors. Solitary
ﬁbrous tumors can be distinguished from strongly positive for
CD34 and lacking S-100 protein stain. Malignant melanomas
should also be considered in S-100 protein-positive adrenal tumors
that can easily be separated by melanoma-associated proteins like
Melan-A and HMB-45.2,4,5
Ancient schwannomas, also described as degenerative neu-
rilemmoma, are rare variants of schwannomas ﬁrst termed in 1951
by Ackerman and Taylor. They are characterized by diffusehypocellularity and degenerative changes.2 Histologic ﬁndings of
ancient schwannomas comprise thick-walled, hyalinized blood
vessels, hyperchromasia, nucleomegaly, hemorrhage, hemosiderin
deposits, cystic formation, and Verocay body, which is always
associatedwith Antoni A. Varying degrees of inﬂammation by small
lymphocytes have also been described.2,4
Adrenal myelolipomas are uncommon benign tumors of the
adrenal cortex, and etiology is still unclear. The most accepted the-
ory was proposed by Meaglia and Schmidt in 1992. They theorized
metaplasia of reticuloendothelial cells of blood capillaries in the
adrenal gland because of stimuli such as infection, stress, and ne-
crosis.6 They also associated it with some chronic diseases like
obesity, hyperthyroidism, diabetes mellitus, hypertension, and
atherosclerosis. Interestingly, cooccurrence of adrenal myelolipoma
and cholelithiasis is extremely rare, just like our case. The association
of obesity with myelolipoma has been well documented and so has
obesity with cholelithiasis.7 However, the connection between ad-
renal myelolipoma and cholelithiasis is unclear. It is an incidental
ﬁnding or a shared common pathophysiology that needs more
studies to clarify. Females are slightly less affected thanmales with a
female-to-male ratio of 1:1.34. Peak prevalence is between 40 years
and 69 years of age. Unilateral with right side predominant is usually
noted. Myelolipomas have been reported at various sites, including
Fig. 3. (A) Antoni B pattern is characterized by hypocellularity within myxoid stroma in the neurilemoma (hematoxylin and eosin stain, 20). (B) Immunohistochemical stain
demonstrates positive reaction with S-100 protein in the neurilemoma (immunohistochemical stain; original magniﬁcation, 10). (C) The myelolipoma is composed of hemato-
poietic elements and mature adipose cells and rimmed by the attenuated adrenal parenchyma (left ﬁeld). (Hematoxylin and eosin stain; original magniﬁcation, 10.) (D) High
power view demonstrates erythroid cells, myeloid cells, and a megakaryocyte (arrowhead) in the myelolipoma and the adjacent adernal cortical cells (arrows). (Hematoxylin and
eosin stain; original magniﬁcation, 40.)
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mediastinum, spleen, liver, mesentery, and lymph nodes.8
Clinically, theyare usually nonsymptomatic ordisplay nonspeciﬁc
behavior due to their small size. The reported diameter varied from
2~3mm to 34 cm. Possible presentations are abdominal/ﬂank pain
followed by spontaneous rupture, palpable mass, nausea/vomiting,
fever, body weight loss, abdominal fullness, and hematuria. They are
usually hormonally nonfunctioning but can be associated with
Cushing syndrome, Conn's syndrome, Addison's disease, congenital
adrenal hyperplasia, adenoma, and pheochromocytoma.6,8 Histopa-
thology of adrenalmyelolipomas revealedmature adipose tissue and
hematopoietic elements in variable proportions. A series of myeloid
cells, either lymphoid or megakaryocytic lymphoid, plasma cells,
calciﬁcation, and ossiﬁcation can also be found.
On CT, ordinary schwannomas appear as well-demarcated,
round, or oval masses that may show homogeneous or heteroge-
neous enhancement. On magnetic resonance imaging, (MRI) they
usually show smooth margin, high intensity on T2-weighted im-
ages, and iso- or hypo-intensity on T1-weighted images. They could
be strongly enhanced by contrast medium. Cystic formation,
calciﬁcation, hemorrhage, hyalinization, or fatty degeneration wasdescribed as the terminal stage of degeneration in long-standing
schwannomas (so-called ancient change). Larger tumor size was
associated with progressive degenerative change.9
In adrenal myelolipoma, typical CT ﬁndings reveal well-
encapsulated, circumscribed heterogeneous lesions, intratumoral
bleed, calciﬁcation, and hematopoietic elements related low-
density. Calciﬁcation may be seen in approximately 27% of
cases.6,7 MRI with fat suppression is the best technique to depict
the presence of adipose tissue, though hemorrhages can cause high
or low intensity, depending on the age of the blood. The diagnosis
must be distinguished from other adipose-containing tumors
including retroperitoneal lipoma or liposarcoma, leiomyosarcoma,
angiomyolipoma, teratoma, metastatic, or primary adrenal
malignancy.8
However, deﬁnite diagnosis of adrenal schwannoma or myeloli-
poma by radiological investigation is not easy due to lack of speciﬁc
imaging criteria. Fine needle biopsy has demonstrated poor reli-
ability by reason of resembling characteristics of malignant and
benign tumors and might result in complications. Therefore, com-
plete laparoscopic surgical resection is recommended, if the tumor is
symptomatic, growing, of a size > 4 cm, or potential malignancy.5,8
K.-F. Yang et al. / Urological Science 26 (2015) 134e138138In our case, CT showed the maximal diameter of a tumor was
7 cm with calciﬁcation and fat components. Teratoma or myeloli-
poma was impressed but malignancy could not be ruled out.
Laparoscopic adrenalectomy was indicated. Furthermore, acute
cholestatic hepatitis and chronic epigastralgia related to cholecys-
titis were observed, therefore cholecystectomy was indicated as
well. Accordingly, combined laparoscopic cholecystectomy and left
adrenalectomy can offer maximal beneﬁt to our patient.10 We
performed the surgery smoothly and convalescence was unevent-
ful. No recurrence was noted after 2 years follow up.4. Conclusion
This is the ﬁrst reported case of ancient schwannoma and
myelolipoma coexisting in one adrenal tumor. For this kind of large,
nonsecreting adrenal incidentaloma, despite sophisticated imaging
modality being performed, we still could not tell benign and ma-
lignancy apart preoperatively. The best management option is
surgical excision. The ﬁnal diagnosis should rely on pathology. The
long-term prognosis for both tumors is good.Conﬂicts of interest
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